Pathophysiology/Neurocircuitry Archives - Page 2 of 7

Cognitive Function & Neuroprotection In Schizophrenia

On-Demand Webinar June 26, 2019

Schizophrenia has a worldwide prevalence of approximately 1%.1 Individuals living with the disease often experience neurocognitive deficits, as well as poor memory and attention, which are considered core symptoms for… Read More

The Neurobiology Of Endocannabinoids

Video June 17, 2019

Hear from Chloe Liu, Ph.D., a Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc., as she examines the historical research discoveries and underlying neurobiological mechanisms of the endocannabinoid… Read More

Revisiting Cognitive Deficits In Bipolar Disorder

On-Demand Webinar June 11, 2019

Neurocognitive deficits are commonly experienced by individuals living with bipolar disorder. Bipolar disorder is known to affect attention, processing speed, verbal learning and memory, and executive functions, including working memory… Read More

The Neurobiology Of Opioids

Video June 10, 2019

Hear from Chip Meyer, Ph.D., a Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc., as he examines the historic medical utilization and underlying neurobiological mechanisms of opioids. Explore… Read More

The Role Of Glutamate In Mood Disorders & Schizophrenia

On-Demand Webinar March 19, 2019

Glutamate is the predominant excitatory neurotransmitter in the nervous system, and glutamatergic dysregulation has been implicated in the pathophysiology of both mood disorders and schizophrenia. In this webinar, Dr. James… Read More

Gender Differences In Depression

On-Demand Webinar March 7, 2019

The prevalence of depressive disorders is higher in women than men. Why? Many factors are thought to contribute to the divergence, including biological and clinical presentations. Understanding these variances may… Read More

Webinar Summary – Gender Differences In Depression

Article March 7, 2019

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/gender-differences-in-depression/. On March 7, 2019,… Read More

Depression: From Molecule To Man

Video February 24, 2019

Dr. Mark M. Rasenick examines the impact of depression in molecules, rodents, primates, and humans from a biological, genetic, and epigenetics perspective. Dr. Rasenick identifies the importance of research derived… Read More

Evolving Pharmacology Of Depression: Beyond The Monoamine Hypothesis

On-Demand Webinar October 9, 2018

According to the World Health Organization, major depressive disorder (MDD) currently impacts 300 million individuals worldwide and is the leading cause of disability globally. Current treatment strategies for depression are… Read More

Webinar Summary – Evolving Psychopharmacology Of Depression: Beyond The Monoamine Hypothesis

Article October 9, 2018

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/evolving-pharmacology-depression-beyond-monoamine-hypothesis/. On October 9, 2018,… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: